RS Investment Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | $978K | Sell |
20,000
-390,548
| -95% | -$19.1M | 0.01% | 327 |
|
|
2016
Q1 | $26M | Buy |
410,548
+26,325
| +7% | +$1.67M | 0.26% | 137 |
|
|
2015
Q4 | $43.1M | Sell |
384,223
-5,950
| -2% | -$667K | 0.39% | 94 |
|
|
2015
Q3 | $37.6M | Buy |
390,173
+41,060
| +12% | +$3.95M | 0.34% | 112 |
|
|
2015
Q2 | $35.7M | Buy |
349,113
+23,952
| +7% | +$2.45M | 0.31% | 124 |
|
|
2015
Q1 | $20.2M | Sell |
325,161
-33,217
| -9% | -$2.06M | 0.18% | 184 |
|
|
2014
Q4 | $15.7M | Buy |
358,378
+147,937
| +70% | +$6.48M | 0.14% | 219 |
|
|
2014
Q3 | $11.9M | Buy |
210,441
+4,900
| +2% | +$277K | 0.11% | 220 |
|
|
2014
Q2 | $9.23M | Buy |
205,541
+26,441
| +15% | +$1.19M | 0.08% | 237 |
|
|
2014
Q1 | $8.76M | Buy |
+179,100
| New | +$8.76M | 0.05% | 236 |
|